BRAF and non-small cell lung carcinoma: For the latter cases, a case report noted that NGS analysis of cerebrospinal fluid ctDNA in BRAF-mutant NSCLC patients with brain metastasis, may potentially provide more accurate information about intracranial lesions than blood serum ctDNA, due to the blood-brain barrier [108].